19.01.2023 16:50:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, HZN, CLXT, VLTA

NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Catalyst Biosciences, Inc. (NASDAQ: CBIO)'s merger with GNI Group Ltd. If you are a Catalyst shareholder, click here to learn more about your rights and options.

Horizon Global Corporation (NYSE: HZN)'s sale to First Brands Group, LLC for $1.75 per share. If you are a Horizon Global shareholder, click here to learn more about your legal rights and options.   

Calyxt, Inc. (NASDAQ: CLXT)'s merger with Cibus. Under the terms of the merger agreement, Calyxt will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will own approximately 5% of the combined company. If you are a Calyxt shareholder, click here to learn more about your rights and options.

Volta Inc. (NYSE: VLTA)'s sale to Shell USA Inc. for $0.86 per share in cash. If you are a Volta shareholder, click here to learn more about your legal rights and options.   

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-cbio-hzn-clxt-vlta-301725863.html

SOURCE Halper Sadeh LLP

Nachrichten zu Catalyst Biosciences Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Catalyst Biosciences Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!